Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lyra Therapeutics, Inc. | President & CEO, Director | Stock Option | 500K | Mar 18, 2024 | Direct | ||
Lyra Therapeutics, Inc. | President & CEO, Director | Common Stock | 300K | Oct 16, 2024 | Direct | ||
Lyra Therapeutics, Inc. | President & CEO, Director | Employee Stock Option (right to buy) | 183K | Dec 9, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LYRA | Lyra Therapeutics, Inc. | Dec 9, 2024 | 1 | $0 | 4 | Dec 11, 2024 | President & CEO, Director |
LYRA | Lyra Therapeutics, Inc. | Oct 16, 2024 | 1 | $0 | 4 | Oct 18, 2024 | President & CEO, Director |
LYRA | Lyra Therapeutics, Inc. | Mar 18, 2024 | 1 | $0 | 4 | Mar 20, 2024 | President & CEO, Director |
LYRA | Lyra Therapeutics, Inc. | Jun 15, 2023 | 1 | $0 | 4/A | Jul 12, 2023 | President & CEO, Director |
LYRA | Lyra Therapeutics, Inc. | Jan 31, 2023 | 1 | $0 | 4 | Feb 2, 2023 | President & CEO, Director |
LYRA | Lyra Therapeutics, Inc. | Feb 16, 2022 | 1 | $0 | 4 | Feb 18, 2022 | President & CEO, Director |
LYRA | Lyra Therapeutics, Inc. | Feb 12, 2022 | 1 | $0 | 4 | Feb 15, 2022 | President & CEO, Director |